tiprankstipranks
Trending News
More News >
Modern Chinese Medicine Group Co. Ltd. (HK:1643)
:1643
Hong Kong Market
Advertisement

Modern Chinese Medicine Group Co. Ltd. (1643) Financial Statements

Compare
0 Followers

Modern Chinese Medicine Group Co. Ltd. Financial Overview

Modern Chinese Medicine Group Co. Ltd.'s market cap is currently HK$410.40M. The company's EPS TTM is HK$0.03; its P/E ratio is 32.57; Modern Chinese Medicine Group Co. Ltd. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 214.07M¥ 344.07M¥ 399.66M¥ 360.69M¥ 308.69M
Gross Profit¥ 55.20M¥ 104.17M¥ 170.79M¥ 158.43M¥ 136.86M
Operating Income¥ 22.33M¥ 66.87M¥ 124.34M¥ 114.30M¥ 90.72M
EBITDA¥ 29.82M¥ 74.75M¥ 130.03M¥ 117.02M¥ 92.56M
Net Income¥ 9.67M¥ 48.80M¥ 87.83M¥ 81.78M¥ 63.58M
Balance Sheet
Cash & Short-Term Investments¥ 229.67M¥ 286.27M¥ 282.26M¥ 176.09M¥ 73.19M
Total Assets¥ 540.31M¥ 528.53M¥ 501.53M¥ 395.94M¥ 209.26M
Total Debt¥ 135.00K¥ 72.00K¥ 393.00K¥ 410.00K¥ 5.54M
Net Debt¥ -229.53M¥ -286.19M¥ -281.86M¥ -175.68M¥ -67.65M
Total Liabilities¥ 56.08M¥ 55.64M¥ 78.60M¥ 58.58M¥ 74.43M
Stockholders' Equity¥ 484.23M¥ 472.89M¥ 422.93M¥ 337.36M¥ 134.83M
Cash Flow
Free Cash Flow¥ -55.32M¥ 3.38M¥ 114.06M¥ -12.87M¥ 42.22M
Operating Cash Flow¥ 58.98M¥ 8.48M¥ 125.79M¥ 57.60M¥ 42.76M
Investing Cash Flow¥ -115.49M¥ -4.19M¥ -11.05M¥ -70.05M¥ -408.00K
Financing Cash Flow¥ -144.00K¥ -326.00K¥ -8.73M¥ 115.76M¥ -5.05M
Currency in CNY

Modern Chinese Medicine Group Co. Ltd. Earnings and Revenue History

Modern Chinese Medicine Group Co. Ltd. Debt to Assets

Modern Chinese Medicine Group Co. Ltd. Cash Flow

Modern Chinese Medicine Group Co. Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis